Global Transdermal Medical Patch Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Medical Patch Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Transdermal Medical Patch report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Medical Patch market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Offline Channel and Online Channel are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Medical Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Medical Patch key manufacturers include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal and IBSA Group, etc. Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis are top 3 players and held % sales share in total in 2022.
Transdermal Medical Patch can be divided into Methyl Salicylate-Based Patch, Rivastigmine Patch, Fentanyl Patch and Lidocaine Patch, etc. Methyl Salicylate-Based Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Medical Patch is widely used in various fields, such as Offline Channel and Online Channel, etc. Offline Channel provides greatest supports to the Transdermal Medical Patch industry development. In 2022, global % sales of Transdermal Medical Patch went into Offline Channel filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Medical Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others
Offline Channel
Online Channel
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Medical Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Medical Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Medical Patch industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Medical Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Medical Patch introduction, etc. Transdermal Medical Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Medical Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Transdermal Medical Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Medical Patch key manufacturers include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal and IBSA Group, etc. Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis are top 3 players and held % sales share in total in 2022.
Transdermal Medical Patch can be divided into Methyl Salicylate-Based Patch, Rivastigmine Patch, Fentanyl Patch and Lidocaine Patch, etc. Methyl Salicylate-Based Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Medical Patch is widely used in various fields, such as Offline Channel and Online Channel, etc. Offline Channel provides greatest supports to the Transdermal Medical Patch industry development. In 2022, global % sales of Transdermal Medical Patch went into Offline Channel filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Medical Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others
Segment by Application
Offline Channel
Online Channel
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Medical Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Medical Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Medical Patch industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Medical Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Medical Patch introduction, etc. Transdermal Medical Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Medical Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.